- About Us
- Nano-Social Network
- Nano Consulting
- My Account
In 2003, I wrote the book, "The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business." In it, I outlined the many ways in which nanotechnology will impact the pharmaceutical industry in the near future. Recently, researchers at Children's Hospital in Boston have uncovered a method of reviving a once-promising cancer drug, TNP-470—which was cancelled in the mid-1990's due to concerns over toxicity.
The problem of toxicity is not a new one to the pharmaceutical industry. In fact, it is a big reason why so many early stage drugs fail to make it to market.
This vexing problem may soon be partially alleviated due to advances in nanotechnology. One advantage of reformulating drugs at the nanoscale is that they are water soluble and, as such, don't require the solvents which so often cause nasty side-effects in patients.
Another application being employed from the nanotechnology bag of tricks is to use nanoscale platforms such as micelles and dendrimers to prevent drugs from crossing the blood-brain barrier. In this fashion, older drugs may be reformulated so as to prevent certain drugs from wreaking havoc on the human brain. (This was one of the problems with TNP-470).
The pharmaceutical industry has invested billions of dollars developing promising drugs. Unfortunately, most developmental drugs end being shelved when it is found they cause some unintended consequence. Nanotechnology holds the promise that a handful of older drugs may now be revisited. Some may even find their way to the commercial marketplace.
With a single drug's ability to add billions of dollars to a pharmaceutical company's bottom-line, it is time many of them begin turning their attention to nanotechnology. It's a small technology, but it could pay big dividends.
About Jack Uldrich
Jack Uldrich is a renowned global futurist, independent scholar, sought-after business speaker, and best-selling author. His books include the best-selling, The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business, and the award-winning, Into the Unknown: Leadership Lessons from Lewis & Clark’s Daring Westward Expedition. His latest book is Jump the Curve: 50 Essential Strategies to Help Your Company Stay Ahead of Emerging Technologies.
For more information, please click here
Copyright © Jack UldrichIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017
Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016
Peter Diamandis Thinks Nanotech Will Interface With Human Minds September 1st, 2016
Graphene-Enabled Paper Makes for Flexible Display August 1st, 2016
Marrying superconductors, lasers, and Bose-Einstein condensates: Chapman University Institute for Quantum Studies (IQS) member Yutaka Shikano, Ph.D., recently had research published in Scientific Reports June 20th, 2016